Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    -0.11 (-8.40%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Tern PLC: DA Security Blueprint

22 Jun 2018 07:01

Tern PLC (TERN) Tern PLC: DA Security Blueprint 22-Jun-2018 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


22 June 2018

Tern Plc (the "Company", or the "Group")

DA Security Blueprint

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Thing ("IoT"), has been advised, further to the announcement made on 8 June 2018, that preliminary marketing of Thales' healthcare IoT security blueprint, developed in conjunction with Device Authority ("DA"), has commenced.

 

Tern has a 56.8% holding in IoT security business, DA, and this represents a significant milestone for DA following the formation of its strategic partnership with Thales Group announced on 24 January 2018. The healthcare IoT security blueprint provides high-assurance device authentication, managed end-to-end encryption, and certificate provisioning for IoT devices, ideal for medical, industrial and other smart connected products.

 

According to the 2018 Thales Data Threat Report, the healthcare industry is regularly targeted by cybercriminals with 70 per cent. of healthcare organisations globally having experienced an attack. This solution is designed to enable the Connected Health industry to continue to perform at the highest levels without question on the integrity of data or medical devices.

Tern CEO, Al Sisto, said: "We are delighted to have been advised that Thales and DA have further strengthened their strategic partnership with the issue of this joint blueprint. This clearly shows how DA can provide the level of IoT security required in healthcare/medical cases and is another step in expanding Tern's participation in the medical IoT markets via its portfolio investee companies to create shareholder value."

 

**ENDS**

 

Enquiries

Tern Plc

Al Sisto/Sarah Payne

via Redleaf Communications

 

WH Ireland

(NOMAD and joint broker)

Mike Coe/Ed Allsopp

 

Tel: 0117 945 3470

 

Whitman Howard

(Joint broker)

Nick Lovering/Francis North

 

Tel: 020 7659 1234

 

Redleaf Communications

Elisabeth Cowell/Fiona Norman

 

Tel: 020 3757 6880

 

 

 


ISIN:GB00BFPMV798
Category Code:MSCH
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:5670
EQS News ID:697871
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.